Literature DB >> 20211660

Colocalization of mineralocorticoid and EGF receptor at the plasma membrane.

Claudia Grossmann1, Britta Husse, Sigrid Mildenberger, Barbara Schreier, Katja Schuman, Michael Gekle.   

Abstract

The mineralocorticoid receptor (MR), a ligand-activated transcription factor expressed in various cell types (e.g. epithelial cells, neurons, smooth muscle cells, immune cells), plays important roles in neurohumoral, neuronal, cardiovascular, renal and intestinal function. Pathophysiological relevant signaling mechanisms include nongenomic pathways involving the EGF receptor (EGFR). We investigated whether a MR-EGFR colocalization may underlie the functional MR-EGFR interaction by coimmunoprecipitation, fluorescence resonance energy transfer (FRET) and confocal microscopy in a heterologous expression system. EGFR and a small fraction of MR colocalize at the cell membrane, independently of short time exposure (</=60min) to receptor ligands. Twenty-four-hour-exposure to saturating concentrations of aldosterone (10nmol/l) resulted in an almost complete nuclear translocation of MR and disappearance of MR-EGFR colocalization. EGFR transactivation is enhanced only after MR stimulation. Inhibition of HSP90 by geldanamycin did not reduce the fraction of MR interacting with EGFR. Disruption of cholesterol-rich membrane domains by cyclodextrin reduced MR-EGFR interaction. In conclusion, a subfraction of MR interacts with EGFR at the plasma membrane in our heterologous expression system, possibly at cholesterol-rich domains, to form a steroid receptor/growth factor receptor signaling module. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211660     DOI: 10.1016/j.bbamcr.2010.02.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies.

Authors:  Celso E Gomez-Sanchez; Mary Warden; Miriam T Gomez-Sanchez; Xu Hou; Elise P Gomez-Sanchez
Journal:  Steroids       Date:  2011-09-10       Impact factor: 2.668

Review 2.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

3.  Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury.

Authors:  Anthony W Ashton; Thi Y L Le; Celso E Gomez-Sanchez; Marie-Christine Morel-Kopp; Brett McWhinney; Amanda Hudson; Anastasia S Mihailidou
Journal:  Mol Endocrinol       Date:  2015-06-29

4.  Mineralocorticoid receptor activation is crucial in the signalling pathway leading to the Anrep effect.

Authors:  Claudia I Caldiz; Romina G Díaz; Mariela B Nolly; Gladys E Chiappe de Cingolani; Irene L Ennis; Horacio E Cingolani; Néstor G Pérez
Journal:  J Physiol       Date:  2011-12-15       Impact factor: 5.182

5.  Lipid raft- and protein kinase C-mediated synergism between glucocorticoid- and gonadotropin-releasing hormone signaling results in decreased cell proliferation.

Authors:  Lancelot Wehmeyer; Andrea Du Toit; Dirk M Lang; Janet P Hapgood
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

Review 6.  The Interface of Nuclear and Membrane Steroid Signaling.

Authors:  Lindsey S Treviño; Daniel A Gorelick
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

Review 7.  The autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activation.

Authors:  Irene L Ennis; Ernesto A Aiello; Horacio E Cingolani; Nestor G Perez
Journal:  Curr Cardiol Rev       Date:  2013-08

Review 8.  OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.

Authors:  Richard E Kast; Marc-Eric Halatsch; Rafael Rosell
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

9.  Mitochondrial reactive oxygen species (ROS) as signaling molecules of intracellular pathways triggered by the cardiac renin-angiotensin II-aldosterone system (RAAS).

Authors:  V C De Giusti; C I Caldiz; I L Ennis; N G Pérez; H E Cingolani; E A Aiello
Journal:  Front Physiol       Date:  2013-05-30       Impact factor: 4.566

Review 10.  Modulation of the cardiac sodium/bicarbonate cotransporter by the renin angiotensin aldosterone system: pathophysiological consequences.

Authors:  Verónica C De Giusti; María C Ciancio; Alejandro Orlowski; Ernesto A Aiello
Journal:  Front Physiol       Date:  2014-01-17       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.